Skip to content

Mosquito species native to tigers become the first carriers of chikungunya virus in Alsace region

Mosquito Warning in Strasbourg: Tiger Mosquito Carries Tropical Disease for the First Time - Public Advised to Remain Vigilant

Mosquitoes of the tiger variety are identified as the carriers of chikungunya virus for the first...
Mosquitoes of the tiger variety are identified as the carriers of chikungunya virus for the first time in Alsace.

Mosquito species native to tigers become the first carriers of chikungunya virus in Alsace region

In a recent development, the Chikungunya virus has been detected in the Alsace region of France, specifically in the municipality of Lipsheim near Strasbourg. This marks the first such case ever reported in the French neighboring region.

The infected individual, a resident of Lipsheim, has not recently travelled abroad, suggesting the infection occurred in Alsace. The virus, an acute viral disease transmitted by mosquito bites, primarily by *Aedes aegypti* and *Aedes albopictus* mosquitoes, causes symptoms such as high fever, intense joint pain, muscle pain, headache, skin rash, extreme fatigue, nausea and vomiting, and digestive disorders.

Chikungunya, which means "bent over" in the Kimakonde language of Tanzania, due to the posture adopted by those suffering from the disease's severe joint pain, typically manifests within 2 to 14 days after exposure. Other symptoms include nausea, vomiting, fatigue, photophobia, conjunctivitis, nasal discharge, retrobulbar pain, and lymphadenopathy. Hemorrhagic manifestations are rare and mostly reported only in Asia.

The virus causes inflammation partly through interactions with immune cells, leading to elevated cytokines that contribute to symptoms and severity. There is no specific antiviral treatment approved for Chikungunya virus. Treatment focuses on symptom relief, with rest, hydration, and the use of analgesics and antipyretics such as acetaminophen or paracetamol (preferred initially, especially if dengue is a concern to avoid bleeding risks). Nonsteroidal anti-inflammatory drugs (NSAIDs) for joint pain and inflammation, corticosteroids, and physical therapy may help with persistent joint pain.

To prevent the spread of the virus, it's crucial to avoid mosquito bites during illness. This can be achieved by covering water containers tightly or equipping them with a mosquito net, ensuring proper drainage of gutters, and collecting green waste that could otherwise attract adult mosquitoes. The regional health agency (ARS) also recommends preventive measures to limit the proliferation of mosquitoes around settlements.

Mosquito control actions have been undertaken in the affected area. The first action took place on the night of July 1st to 2nd, within a 150-meter radius around the house of the infected person. A second action is scheduled for one week later.

It's important to note that the department of Bas-Rhin around Strasbourg is affected by the tiger mosquito, which is capable of transmitting the virus. However, the exact source of the virus in Alsace and the number of people potentially affected remains unclear.

While the disease is rarely fatal, deaths from Chikungunya are more common among the elderly, immunocompromised individuals, or newborns. Joint pain from Chikungunya can be particularly severe and may persist for several weeks to years, potentially leading to work disability.

This local transmission serves as a reminder to stay vigilant and follow preventive measures to limit the proliferation of mosquitoes and the spread of diseases like Chikungunya. For more information, consult your local health authority or visit reputable health websites.

  1. In the realm of science, preventive measures are crucial for limiting the proliferation of mosquitoes and the spread of diseases like Chikungunya.
  2. The first reported case of Chikungunya in the French neighboring region was detected in Lipsheim, a municipality near Strasbourg.
  3. Chikungunya, an acute viral disease, primarily spreads through the bites of mosquitoes such as Aedes aegypti and Aedes albopictus.
  4. While medical-conditions associated with Chikungunya are rare, hemorrhagic manifestations are mostly reported in Asia.
  5. The elimination of potential breeding sites for mosquitoes, like covered water containers and properly drained gutters, has a significant impact on preventing the spread of Chikungunya.
  6. According to the regional health agency (ARS), vigilant work in mosquito control can lessen the severity of outbreaks, as demonstrated by the actions taken in the affected area of Bas-Rhin.
  7. Climate-change, especially in areas like tropical and subtropical regions where the primary mosquito vectors thrive, might contribute to a global rise in Chikungunya cases.
  8. The health-and-wellness implications of Chikungunya extend beyond the disease itself, as joint pain can persist for weeks to years and potentially lead to work disability in some individuals, particularly the elderly or immunocompromised.
  9. Although Chikungunya is rarely fatal, it can be more dangerous for pregnant women, newborns, and people with certain medical-conditions, like neurological-disorders or compromised immune systems.
  10. In skin-care routines, CBD products may offer potential benefits for alleviating joint pain and inflammation, in addition to their well-known therapeutic uses for mental-health and neurological-disorders.
  11. Importantly, practices like parenting, fitness-and-exercise, weight-management, and men's-health, all fall under the umbrella of health-and-wellness, and are essential for building a strong foundation for protecting individuals from the effects of Chikungunya and other infectious diseases.

Read also:

    Latest